MOREPENLAB logo

Morepen LAB. LTD

MOREPENLAB·NSE·
108.67 +5.02 (+4.84%)
Market Cap6002.83 Cr
PE Ratio62.82
Volume1,20,69,818
Day High - Low110.00 - 103.55
52W High-Low110.50 - 33.05
DocStoX Score
3.5/10
Poor
Fair Value
Sign in to see
ROE
6.20%
Weak
P/E
62.82x
Expensive
Debt / Equity
0.16
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

Day103.55
110.00
52W33.05
110.50
DocStoX take

Supported by momentum (7.5) and risk (6.6), but held back by valuation (0.0). Momentum looks strong at 7.5, but that is offset by valuation at 0.0 and growth at 2.1 and quality at 2.6. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
3.5
/10
Poor
Quality
Weak
ROE 6.2%
Valuation
Expensive
P/E 62.8×
Growth
Flat
Revenue +8.7% 5Y CAGR
Risk
Moderate
D/E 0.16
Momentum
Strong
98% of 52-week range

At a glance

Market Cap
₹6,003 Cr
52W High / Low
₹111 / ₹33
Dividend Yield
0.21%
Promoter Holding
35.65%
EPS (TTM)
₹1.73
Book Value
₹22.80

Key highlights

  • Low leverage — D/E 0.16
  • Profitable in all of the last 5 years
  • Profit shrinking 0% a year
  • Valuation is weak (0.0/10)
2 Positives4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

MOREPEN LAB. LTD peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.